anubhai
Back OfficeBajaj Finserv Healthcare Fund - Regular (G)
Summary
| Fund Name | Bajaj Finserv Mutual Fund |
| Scheme Name | Bajaj Finserv Healthcare Fund - Regular (G) |
| AMC | Bajaj Finserv Mutual Fund |
| Type | Open |
| Category | Equity - Pharma |
| Launch Date | 06-Dec-2024 |
| Fund Manager | Vinay Bafna |
| Net Assets(Rs. cr) | 354.03 |
NAV Graph
Latest Payouts
| Dividends | Bonus |
|---|
Performance
| 1 Week (%) | 1 Month (%) | 3 Month (%) | 6 Month (%) | 1 Year (%) | 3 Year (%) | 5 Year (%) | Since INC (%) | |
|---|---|---|---|---|---|---|---|---|
| Scheme Return | 2.19 | 4.54 | 15.48 | 23.76 | 13.24 | 0.00 | 0.00 | 8.30 |
| Category Avg | 1.85 | 4.39 | 14.00 | 23.90 | 12.04 | 21.30 | 15.20 | 17.55 |
| Category Best | 2.58 | 5.79 | 17.47 | 31.91 | 20.06 | 24.64 | 18.66 | 31.92 |
| Category Worst | 1.08 | 2.43 | 8.17 | 14.84 | 3.88 | 17.94 | 11.79 | 6.68 |
Asset Allocation
Holdings
| Company Name | % Hold |
|---|---|
| Divi's Lab. | 8.40 |
| Apollo Hospitals | 6.71 |
| Aurobindo Pharma | 6.52 |
| Sun Pharma.Inds. | 6.36 |
| Piramal Pharma | 6.04 |
| Rubicon Research | 6.02 |
| Torrent Pharma. | 5.26 |
| Neuland Labs. | 4.59 |
| Emcure Pharma | 4.36 |
| Max Healthcare | 4.16 |
| Fortis Health. | 3.25 |
| Zydus Wellness | 2.82 |
| Ipca Labs. | 2.43 |
| Vijaya Diagnost. | 2.36 |
| Senores Pharma. | 2.29 |
| Navin Fluo.Intl. | 2.17 |
| Laurus Labs | 2.14 |
| Shaily Engineer. | 2.03 |
| Sanofi Consumer | 1.80 |
| Glenmark Pharma. | 1.73 |
| Glaxosmi. Pharma | 1.65 |
| Dr Lal Pathlabs | 1.64 |
| Zydus Lifesci. | 1.40 |
| Biocon | 1.35 |
| Abbott India | 1.25 |
| Medplus Health | 1.18 |
| Krishna Institu. | 1.15 |
| Medi Assist Ser. | 1.04 |
| ERIS Lifescience | 1.01 |
| Turtlemint Finte | 1.00 |
| Jubilant Pharmo | 0.96 |
| Astrazeneca Phar | 0.76 |
| MTAR Technologie | 0.32 |
| C C I | 1.41 |
| Net CA & Others | 0.96 |
| Bajaj Finserv Money Market Fund - Direct (G) | 1.48 |
